Jump to main content
Jump to site search
PLANNED MAINTENANCE Close the message box

Scheduled maintenance upgrade on Thursday 4th of May 2017 from 8.00am to 9.00am (BST).

During this time our websites will be offline temporarily. If you have any questions please use the feedback button on this page. We apologise for any inconvenience this might cause and thank you for your patience.


Issue 10, 2009
Previous Article Next Article

Quantification of cisplatin, carboplatin and oxaliplatin in spiked human plasma samples by ICP-SFMS and hydrophilic interaction liquid chromatography (HILIC) combined with ICP-MS detection

Author affiliations

Abstract

Therapeutic drug monitoring addresses the determination of the free and intact drug in patient blood. The free fraction of cancerostatic platinum compounds (CPC) is determined by measurement of total platinum levels in plasma ultrafiltrate. In this work, as a starting point, the distribution of cisplatin, carboplatin and oxaliplatin among different blood compartments, i.e. whole blood, plasma, residue (pellet fraction), plasma-ultrafiltrate and protein-residue fraction, was assessed in an ex vivo experiment via ICP-SFMS measurement of total platinum after microwave digestion. The results clearly showed that the distribution is independent of the initial concentration but dependent on the used drug. The platinum in the plasma-ultrafiltrate amounted to 16.8 ± 1.3%, 56.8 ± 0.1% and 10.4 ± 1.0% for cisplatin, carboplatin and oxaliplatin, respectively. Acetonitrile precipitation of plasma samples delivered corresponding results simplifying and accelerating (5 min vs. 150 min for plasma ultrafiltration and total digestion) sample preparation. This method could be ideally combined with a novel speciation analytical approach using hydrophilic interaction liquid chromatography (HILIC) with ICP-QMS detection. A comparison of the total platinum levels to species selective results revealed that 88.0 ± 12.0% of cisplatin and 106.4 ± 7.7% of carboplatin were present as parent drug, whereas only 34.3 ± 0.4% of oxaliplatin were present in the intact state.

Graphical abstract: Quantification of cisplatin, carboplatin and oxaliplatin in spiked human plasma samples by ICP-SFMS and hydrophilic interaction liquid chromatography (HILIC) combined with ICP-MS detection

Back to tab navigation
Please wait while Download options loads

Publication details

The article was received on 07 Apr 2009, accepted on 20 Jul 2009 and first published on 03 Aug 2009


Article type: Paper
DOI: 10.1039/B907011G
Citation: J. Anal. At. Spectrom., 2009,24, 1336-1342
  •   Request permissions

    Quantification of cisplatin, carboplatin and oxaliplatin in spiked human plasma samples by ICP-SFMS and hydrophilic interaction liquid chromatography (HILIC) combined with ICP-MS detection

    T. Falta, G. Koellensperger, A. Standler, W. Buchberger, R. M. Mader and S. Hann, J. Anal. At. Spectrom., 2009, 24, 1336
    DOI: 10.1039/B907011G

Search articles by author